Brought to you by 
Abbott pays $400mm in cash for IOL specialist Visiogen
29 Sep 2009
Executive Summary
Just eight months after paying $2.86bn for Advanced Medical Optics, Abbott is getting further exposure to the vision care market by acquiring private ophthalmic device company Visiogen for $400mm in cash.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Abbott pays $400mm in cash for IOL specialist Visiogen
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice